UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year ...

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

VERONA, Wis. — The five people killed in a single car crash in the Town of Verona on Nov. 1 have been identified as: Michelle and Jeff Bauer of Crandon, Josh and Tammy Stahl of Brooklyn Park, Minn., ...

Find the latest Verona Pharma plc (VRNA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.